USA risk losing global leadership in nanotech

According to a new report from Lux Research, “In terms of sheer volume, The U.S. dominated the rest of the world in nanotech funding and new patents last year (…). But (…) countries such as China and Russia launched new challenges to U.S. dominance in 2009, while smaller players such as Japan, Germany and South Korea surpassed the United States in terms of commercializing nanotechnology and products.” (press release)

 [[[ Additional links suggested by Nanocolors :

Has China already passed America in nanotechnology?

Nano-related patents – the most visible countries 

Ranking the nations on nanotech ]]]

Gates Foundation funds innovative global health projects including sweat-triggered vaccine delivery using nanoparticles

The Bill & Melinda Gates Foundation announced a few days ago 78 grants of US$100,000 each for new innovative global health projects. Among those aiming at more effective vaccines, one involves nanoparticles : “Sweat-triggered vaccine delivery: Carlos Alberto Guzman of the Helmholtz Centre for Infection Research in Germany with Claus-Michael Lehr and Steffi Hansen of the Helmholtz-Institute for Pharmaceutical Research will develop nanoparticles that penetrate the skin through hair follicles and burst upon contact with human sweat to release vaccines.” (press release)

[[[ Additional link suggested by Nanocolors :

# Nano & vaccines in patents since 2000 ]]]

Dresden and Grenoble nanotechnology clusters strengthen their cooperation

In order to better face competition – especially from Asia – the two most important European nanoelectronics & nanotechnology clusters (Dresden in Germany and Grenoble in France) will strengthen their cooperation in the coming months.  They will set up common expert committees regarding education, R&D, industrial coordination, SMEs and environment ; the first common projects are expected to be launched by the end of 2010 (article).


The Nanomaterials09 conference will take place on June 16-18, 2009 in Bonn (Germany). It will focus on the commercialisation of nanomaterials, rather than technology and theoretical benefits. The conference will be structured into five parallel sessions :  Thin films and printed electronics ; Nanoplastics and nanocomposites  ; Nanobiotechnology and consumer products ; Coating, ink and pigments ; Clean technology (programme summary). In addition, two plenary sessions will address the issues concerning the entire nanomaterials industry.


Nano-map is a graphical tool for the visualization of the regional distribution of relevant nanotechnology institutions in Germany. It is possible to select the kind of institutions, the application fields and the technologies one is interested in, and then to visualize the results at either the country or the regional scale.

Nanotechnology at NIOSH

NIOSH (National Institute for Occupational Safety and Health) is, among others, “conducting research and providing guidance on the occupational safety and health implications and applications of nanotechnology” and has a dedicated page on its website.

Among recent news :

* NIOSH is leading the formation of a workshop by the OECD (Organization for Economic Cooperation and Development) on the assessment and mitigation of workplace exposures to nanomaterials. It will be held on October 20, 2008 in Frankfurt (Germany).

* Four NIOSH researchers are part of the recently created International Alliance for NanoEHS Harmonization (IANH) (see this post).

Additionnally, on the NIOSH Science Blog, can for example be read an article about the following debate : “Should carbon nanotubes be handled in the workplace like asbestos?

Extension of the Merck KGaA / NanoTerra alliance

The German pharmaceutical company Merck KGaA extends its existing strategic partnership with NanoTerra, a company specialized in nanotechnologies (08/10/2008). Read the press release in English here. Extract : “The original agreement between the companies, announced in February 2007, was to develop innovative, nanotechnology-based products and solutions based on Merck’s materials. After successfully meeting initial development milestones, this new agreement will focus on specific application development for Merck customers and moving the technical capabilities into the marketplace for commercialization.”